Exploration of SIK2-signaling in ovarian cancer with CCNE1-amplification3

• Applicants: Professor Dr. Stefan Knapp; Dr. Monika Raab
• Subject Area: Cell Biology
• Term: from 2018 to 2021
• Project identifier: Deutsche Forschungsgemeinschaft (DFG) - Project number 397659447

• Final Report Year: 2021

Final Report Abstract

No abstract available

Publications

• Structure-Based Design of Selective Salt-Inducible Kinase Inhibitors. J Med Chem 2021; 64: 8142-8160
  Tesch R, Rak M, Raab M, Berger LM, Kronenberger T, Joerger AC et al.
  (See online at https://doi.org/10.1021/acs.jmedchem.0c02144)
• The Small-Molecule Inhibitor MRIA9 Reveals Novel Insights into the Cell Cycle Roles of SIK2 in Ovarian Cancer Cells. Cancers (Basel) 2021; 13
  Raab M, Rak M, Tesch R, Gasimli K, Becker S, Knapp S et al.
  (See online at https://doi.org/10.3390/cancers13153658)